Literature DB >> 7537386

Exocrine pancreatic function in the early phase of human acute pancreatitis.

J E Domínguez-Muñoz1, O Pieramico, M Büchler, P Malfertheiner.   

Abstract

BACKGROUND: Little is known about exocrine pancreatic function during human acute pancreatitis. We aimed to evaluate interdigestive exocrine pancreatic secretion and pancreatic polypeptide (PP) release during the early phase of acute pancreatitis in humans.
METHODS: Eight patients with acute pancreatitis (six biliary, one alcoholic, and one idiopathic acute pancreatitis) were studied within 72 h from the onset of symptoms. Four patients had necrotizing and four had edematous acute pancreatitis. Normal values were obtained from 26 normal subjects matched by sex and age. Interdigestive pancreatic secretion was studied by a duodenal intubation perfusion technique. Enzyme output was calculated for consecutive 15-min periods over 3-4 h and expressed as units per hour within a secretion cycle and units per hour around a secretion peak. Plasma PP concentrations were measured by radioimmunoassay in 15-min intervals.
RESULTS: All variables studied were similar in patients with acute pancreatitis and in controls. PP release in acute pancreatitis was maintained in a normal cyclical pattern closely related to the secretory cycles.
CONCLUSIONS: Interdigestive exocrine pancreatic secretion in the early phase of mild to moderate acute pancreatitis in humans remains within the normal range. This finding provides a rational basis for early therapeutic inhibition of pancreatic secretion in human acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537386     DOI: 10.3109/00365529509093260

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  Enteral nutrition and acute pancreatitis.

Authors:  Q P Chen
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 2.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  [1997 gastroenterology update--II].

Authors:  W Fischbach; V Gross; J Schölmerich; C Ell; P Layer; W E Fleig
Journal:  Med Klin (Munich)       Date:  1998-03-15

4.  A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis.

Authors:  W Uhl; M W Büchler; P Malfertheiner; H G Beger; G Adler; W Gaus
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 5.  Late outcome after acute pancreatitis: functional impairment and gastrointestinal tract complications.

Authors:  L Fernández-Cruz; S Navarro; A Castells; A Sáenz
Journal:  World J Surg       Date:  1997-02       Impact factor: 3.352

Review 6.  Acute pancreatitis: risk of recurrence and late consequences of the disease.

Authors:  Juhani Sand; Isto Nordback
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07-07       Impact factor: 46.802

7.  Moving beyond the 'pancreatic rest' in severe and critical acute pancreatitis.

Authors:  Maxim S Petrov
Journal:  Crit Care       Date:  2013-07-01       Impact factor: 9.097

8.  Immediate enteral nutrition can accelerate recovery and be safe in mild acute pancreatitis: A meta-analysis of randomized controlled trials.

Authors:  Qing-Hua Guo; Xin-Yi Tian; Yue-Lan Qin; Xiao-Tong Han; Weihong Wang
Journal:  Heliyon       Date:  2022-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.